D.E. Shaw & Co’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Sell
19,500
-7,800
-29% -$3.73M 0.01% 1621
2025
Q4
$15.9M Buy
27,300
+2,600
+11% +$1.33M 0.01% 1391
2025
Q3
$11.3M Buy
24,700
+16,100
+187% +$6.01M 0.01% 1580
2025
Q2
$2.6M Buy
8,600
+100
+1% +$29.8K ﹤0.01% 2548
2025
Q1
$2.82M Hold
8,500
﹤0.01% 2347
2024
Q4
$2.62M Buy
+8,500
New +$2.39M ﹤0.01% 2515
2024
Q3
Sell
-900
Closed -$252K 4747
2024
Q2
$252K Sell
900
-8,200
-90% -$1.95M ﹤0.01% 3980
2024
Q1
$2.43M Buy
+9,100
New +$2.14M ﹤0.01% 2478
2021
Q4
Sell
-10,000
Closed -$798K 5575
2021
Q3
$798K Hold
10,000
﹤0.01% 3777
2021
Q2
$974K Buy
10,000
+6,200
+163% +$734K ﹤0.01% 3565
2021
Q1
$444K Buy
+3,800
New +$443K ﹤0.01% 3557
2020
Q1
Sell
-10,000
Closed -$911K 4118
2019
Q4
$911K Sell
10,000
-10,000
-50% -$970K ﹤0.01% 3056
2019
Q3
$1.72M Sell
20,000
-10,000
-33% -$938K ﹤0.01% 2468
2019
Q2
$3.14M Buy
30,000
+9,200
+44% +$985K ﹤0.01% 1930
2019
Q1
$2.6M Buy
20,800
+10,000
+93% +$1.24M ﹤0.01% 1977
2018
Q4
$1.22M Buy
+10,800
New +$1.67M ﹤0.01% 2527

Other funds holding MDGL